IRAK-1 is predominantly expressed in CNS microglia, functioning as a negative regulator of the TLR4-MyD88 signaling pathway, and its role in innate immunity, inflammation, and MS has been well established [68, 69]. Here, MYD88 is linked to myeloid sarcoma.